...
首页> 外文期刊>Molecular pharmaceutics >The solubility-permeability interplay when using cosolvents for solubilization: Revising the way we use solubility-enabling formulations
【24h】

The solubility-permeability interplay when using cosolvents for solubilization: Revising the way we use solubility-enabling formulations

机译:使用助溶剂进行增溶时的溶解度-渗透性相互作用:修改了我们使用促溶性配方的方法

获取原文
获取原文并翻译 | 示例

摘要

We have recently reported the interplay between apparent aqueous solubility and intestinal membrane permeability, showing the trade-off between the two when using cyclodextrin- and surfactant-based systems as solubility-enabling formulations. In these cases, the decreased permeability could be attributed directly to decreased free fraction of drug due to the complexation/ micellization inherent in these solubilization methods. The purpose of this study was to investigate the direct solubility - permeability interplay, using formulations in which complexation is not the mechanism for increased solubilization. The apparent aqueous solubility (S aq) and rat intestinal permeability (P eff) of the lipophilic drug progesterone were measured in systems containing various levels of the cosolvents propylene glycol and PEG-400, since this solubilization method does not involve decreased free fraction. Thermodynamic activity was maintained equivalent in all permeability studies (75% equilibrium solubility). Both cosolvents increased progesterone S aq in nonlinear fashion. Decreased P eff with increased S aq was observed, despite the constant thermodynamic activity, and the nonrelevance of free fraction. A mass-transport analysis was developed to describe this interplay. The model considers the effects of solubilization on the membrane permeability (P m) and the unstirred water layer (UWL) permeability (P aq), to predict the overall P eff dependence on S aq. The analysis revealed that (1) the effective UWL thickness quickly decreases with ↑S aq, such that P aq markedly increases with ↑S aq; (2) the apparent membrane/aqueous partitioning decreases with ↑S aq, thereby reducing the thermodynamic driving force for permeability such that P m with ↑S aq; (3) since ↑P aq and P m with ↑S aq, the UWL is shorted out and P eff becomes membrane control with ↑S aq. The model enabled excellent quantitative prediction of P eff as a function of S aq. This work demonstrates that a direct trade-off exists between the apparent solubility and permeability, which must be taken into account when developing solubility-enabling formulations to strike the optimal solubility - permeability balance, in order to maximize the overall oral absorption.
机译:我们最近报道了表观水溶性和肠膜通透性之间的相互作用,显示了当使用基于环糊精和表面活性剂的系统作为增溶制剂时两者之间的权衡。在这些情况下,通透性降低可能直接归因于这些溶解方法固有的络合/胶束化作用,从而导致药物的游离分数降低。这项研究的目的是使用络合不是增加增溶机理的制剂来研究直接溶解度-渗透性相互作用。在含有不同含量的助溶剂丙二醇和PEG-400的系统中,测量了亲脂性药物孕酮的表观水溶性(S aq)和大鼠肠道通透性(P eff),因为这种增溶方法不会降低游离分数。在所有渗透性研究中,热力学活性均保持相等(75%平衡溶解度)。两种助溶剂均以非线性方式增加孕酮S aq。尽管恒定的热力学活性和游离馏分的无关性,但观察到随着S aq的增加,P eff降低。进行了大规模运输分析以描述这种相互作用。该模型考虑了增溶对膜渗透率(P m)和未搅拌水层(UWL)渗透率(P aq)的影响,以预测总P eff对S aq的依赖性。分析显示:(1)有效的UWL厚度随↑S aq迅速减小,使得P aq随↑S aq显着增加; (2)表观膜/水的分配随着↑S aq的减小而减小,从而降低了渗透率的热力学驱动力,使得具有↑S aq的P m减小了。 (3)由于↑P aq和P m与↑S aq相同,因此UWL短路,P eff成为↑S aq的膜控制。该模型能够对P eff作为S aq的函数进行出色的定量预测。这项工作表明,表观溶解度和渗透性之间存在直接的权衡,开发可溶解性的配方以达到最佳溶解度-渗透性平衡时,必须考虑这一点,以最大程度地提高总体口服吸收。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号